Common Contracts
8 similar Employment Agreement contracts by Annexon, Inc., Inhibitor Therapeutics, Inc., Seelos Therapeutics, Inc., Unity Biotechnology, Inc.
INHIBITOR THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 19th, 2022 • Inhibitor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (the “Agreement”), entered into as of December 13, 2022 (the “Effective Date”), is made by and between Inhibitor Therapeutics, Inc., a Delaware corporation (the “Company”) and James A. McNulty (“Executive” and, together with the Company, the “Parties”).
SEELOS THERAPEUTICS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 10th, 2022 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amended and Restated Employment Agreement (this “Agreement”), entered into as of January 10, 2022 (the “Agreement Date”), is made by and between Seelos Therapeutics, Inc., a Nevada corporation (the “Company”), and Raj Mehra, Ph.D. (“Executive” and together with the Company, the “Parties”). This Agreement will become effective as a binding contract as of the date the “Term” under that certain March 20, 2019 Employment Agreement between the Company and the Executive otherwise would expire (such date, the “Effective Date”).
ANNEXON, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 20th, 2020 • Annexon, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into by and between Annexon, Inc., a Delaware corporation (the “Company”) and Michael Overdorf (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of July 2, 2020 (“Offer Letter”).
ANNEXON, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2020 • Annexon, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into by and between Annexon, Inc., a Delaware corporation (the “Company”) and Douglas E. Love, Esq. (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of December 11, 2014 (“Offer Letter”).
ANNEXON, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2020 • Annexon, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into by and between Annexon, Inc., a Delaware corporation (the “Company”) and Ted Yednock (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of December 11, 2014 (“Offer Letter”).
ANNEXON, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2020 • Annexon, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into by and between Annexon, Inc., a Delaware corporation (the “Company”) and Sanjay Keswani (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of April 9, 2019 (“Offer Letter”).
ANNEXON, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2020 • Annexon, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into by and between Annexon, Inc., a Delaware corporation (the “Company”) and Jennifer Lew (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of April 29, 2019 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Keith R. Leonard, Jr. (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and the Company dated as of October 26, 2016 (the “Prior Agreement”).
